Javascript must be enabled for this website to work.

#script { display:none; } #noScript{ width: 350px; height: 175px; text-align: center; background: white; padding: 35px; display: block; margin-top: -87px; top: 50%; position: absolute; border-bottom: 1px solid #c2c2c2; border-left: 1px solid #e6e6e6; border-right: 1px solid #e6e6e6; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; margin-left: 50%; left: -175px; } #noScript img{width:100%;} body{background:#f7f7f7;}

Professional groups call to stop routine pulmonary function testing

All but most urgent surgery cancelled due to COVID-19

Mepolizumab ‘super responders’ seen in severe eosinophilic asthma

GINA: patients should stick with steroids during COVID-19 pandemic

CPAP device maker tasked to make ventilators for COVID-19 surge

holy grail

Pancreatic enzymes worth a look in diabetes

26 Jul 2017

Dr Liza Phillips is an endocrinologist, postdoctoral research fellow, and deputy director of physician training at the University of Adelaide and Royal Adelaide Hospital.

In this week’s holy grail feature the limbic spoke to endocrinologist Dr Liza Phillips about how she is using research in cystic fibrosis to inform diabetes management. Describe the aim of this project in 10 words. To evaluate a new approach to improving blood sugar control in type 2 diabetes. What have you discovered in this ...

Already a member?

Forgot my password

Not a member yet?

Join now for free, independent news relevant to your specialty. the limbic is intended for practicing health care professionals only.

Title: *

First name: *

Last name: *

Country: *

Email: *

Password: *

Password must contain at least 8 characters including 1 letter and 1 number.

AHPRA Number: * Find my AHPRA number

What's your primary area of interest? *

The limbic's weekly newsletter is a round up of key news highlights that's relevant to your specialty. The newsletter may contain advertising and educational or promotional material from carefully selected industry partners including pharmaceutical companies, government and not-for-profit organisations.

You will not receive advertisers only emails and your details will not be shared with any other party.

I would like to receive the limbic newsletter *

I have read and agree to the limbic Terms and Conditions & Privacy Policy *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Top Stories